These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33801580)

  • 41. Reciprocal regulation of Abl kinase by Crk Y251 and Abi1 controls invasive phenotypes in glioblastoma.
    Kumar S; Lu B; Dixit U; Hossain S; Liu Y; Li J; Hornbeck P; Zheng W; Sowalsky AG; Kotula L; Birge RB
    Oncotarget; 2015 Nov; 6(35):37792-807. PubMed ID: 26473374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DOCK5 and DOCK1 regulate Caco-2 intestinal epithelial cell spreading and migration on collagen IV.
    Sanders MA; Ampasala D; Basson MD
    J Biol Chem; 2009 Jan; 284(1):27-35. PubMed ID: 19004829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of CrkL-SH3 binding proteins from embryonic murine brain: implications for Reelin signaling during brain development.
    Cheerathodi M; Ballif BA
    J Proteome Res; 2011 Oct; 10(10):4453-62. PubMed ID: 21879738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physiological signals and oncogenesis mediated through Crk family adapter proteins.
    Feller SM; Posern G; Voss J; Kardinal C; Sakkab D; Zheng J; Knudsen BS
    J Cell Physiol; 1998 Dec; 177(4):535-52. PubMed ID: 10092207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CRKL promotes cell proliferation in gastric cancer and is negatively regulated by miR-126.
    Wang J; Chen X; Li P; Su L; Yu B; Cai Q; Li J; Yu Y; Liu B; Zhu Z
    Chem Biol Interact; 2013 Nov; 206(2):230-8. PubMed ID: 24055140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL.
    Ungewiss C; Rizvi ZH; Roybal JD; Peng DH; Gold KA; Shin DH; Creighton CJ; Gibbons DL
    Sci Rep; 2016 Jan; 6():18652. PubMed ID: 26728244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma.
    Guo C; Gao C; Zhao D; Li J; Wang J; Sun X; Liu Q; Hao L; Greenaway FT; Tian Y; Liu S; Sun MZ
    J Exp Clin Cancer Res; 2020 Apr; 39(1):70. PubMed ID: 32326970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancement of guanine-nucleotide exchange activity of C3G for Rap1 by the expression of Crk, CrkL, and Grb2.
    Ichiba T; Kuraishi Y; Sakai O; Nagata S; Groffen J; Kurata T; Hattori S; Matsuda M
    J Biol Chem; 1997 Aug; 272(35):22215-20. PubMed ID: 9268367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Domain organization differences explain Bcr-Abl's preference for CrkL over CrkII.
    Jankowski W; Saleh T; Pai MT; Sriram G; Birge RB; Kalodimos CG
    Nat Chem Biol; 2012 May; 8(6):590-6. PubMed ID: 22581121
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
    Salgia R; Pisick E; Sattler M; Li JL; Uemura N; Wong WK; Burky SA; Hirai H; Chen LB; Griffin JD
    J Biol Chem; 1996 Oct; 271(41):25198-203. PubMed ID: 8810278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exosomes containing ErbB2/CRK induce vascular growth in premetastatic niches and promote metastasis of bladder cancer.
    Yoshida K; Tsuda M; Matsumoto R; Semba S; Wang L; Sugino H; Tanino M; Kondo T; Tanabe K; Tanaka S
    Cancer Sci; 2019 Jul; 110(7):2119-2132. PubMed ID: 31141251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Erythropoietin and interleukin-3 activate tyrosine phosphorylation of CBL and association with CRK adaptor proteins.
    Barber DL; Mason JM; Fukazawa T; Reedquist KA; Druker BJ; Band H; D'Andrea AD
    Blood; 1997 May; 89(9):3166-74. PubMed ID: 9129019
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.
    Wang Y; Dong QZ; Fu L; Stoecker M; Wang E; Wang EH
    Mol Carcinog; 2013 Nov; 52(11):890-9. PubMed ID: 22753141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CRK proteins selectively regulate T cell migration into inflamed tissues.
    Huang Y; Clarke F; Karimi M; Roy NH; Williamson EK; Okumura M; Mochizuki K; Chen EJ; Park TJ; Debes GF; Zhang Y; Curran T; Kambayashi T; Burkhardt JK
    J Clin Invest; 2015 Mar; 125(3):1019-32. PubMed ID: 25621495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of CT10 regulation of kinase-like in cancer.
    Guo C; Liu S; Sun MZ
    Future Oncol; 2014 Dec; 10(16):2687-97. PubMed ID: 25531052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-429-CRKL axis regulates clear cell renal cell carcinoma malignant progression through SOS1/MEK/ERK/MMP2/MMP9 pathway.
    Wang J; Wang C; Li Q; Guo C; Sun W; Zhao D; Jiang S; Hao L; Tian Y; Liu S; Sun MZ
    Biomed Pharmacother; 2020 Jul; 127():110215. PubMed ID: 32413671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctions.
    Lamorte L; Royal I; Naujokas M; Park M
    Mol Biol Cell; 2002 May; 13(5):1449-61. PubMed ID: 12006644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Crk-like adapter protein is overexpressed in cervical carcinoma, facilitates proliferation, invasion and chemoresistance, and regulates Src and Akt signaling.
    Ji H; Li B; Zhang S; He Z; Zhou Y; Ouyang L
    Oncol Lett; 2016 Nov; 12(5):3811-3817. PubMed ID: 27895735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of CRKL correlates with malignant cell proliferation in breast cancer.
    Zhao T; Miao Z; Wang Z; Xu Y; Wu J; Liu X; You Y; Li J
    Tumour Biol; 2013 Oct; 34(5):2891-7. PubMed ID: 23686806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. USP53 Exerts Tumor-Promoting Effects in Triple-Negative Breast Cancer by Deubiquitinating CRKL.
    Liu Y; Tang W; Yao F
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.